Skip to main content
logo
CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
51.76
+2.06 (4.14%)
At close: Apr 8, 2026, 4:00 PM EDT
51.36
-0.40 (-0.77%)
After-hours: Apr 8, 2026, 7:56 PM EDT

CRISPR Therapeutics AG Revenue

In the year 2025, CRISPR Therapeutics AG had annual revenue of $3.51M, down -90.59%. CRISPR Therapeutics AG had revenue of $864.00K in the quarter ending December 31, 2025, a decrease of -97.58%.

Revenue (ttm)
$3.51M
Revenue Growth
-90.59%
P/S Ratio
1,415.44
Revenue / Employee
$8,931
Employees
393
Market Cap
4.97B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.51M-33.80M-90.59%
Dec 31, 202437.31M-333.89M-89.95%
Dec 31, 2023371.21M370.01M30,885.48%
Dec 31, 20221.20M-913.77M-99.87%
Dec 31, 2021914.96M914.24M127,154.94%
Dec 31, 2020719.00K-288.87M-99.75%
Dec 31, 2019289.59M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Apellis Pharmaceuticals1.00B
Caris Life Sciences812.03M
Corcept Therapeutics761.41M
Amicus Therapeutics634.21M
TG Therapeutics616.29M
Ligand Pharmaceuticals268.09M
Xenon Pharmaceuticals7.50M
Dianthus Therapeutics2.04M
Revenue Rankings

CRSP News

More News